Molecular Devices expands global research and development hub in Austria
Retrieved on:
Wednesday, October 12, 2022
SAN JOSE, Calif., and SALZBURG, Austria, Oct. 12, 2022 /PRNewswire-PRWeb/ -- At a ribbon-cutting ceremony today, Molecular Devices, LLC., a leading provider of high-performance life science solutions, celebrated the completed expansion of its Austrian Research & Development Center. In support of the company's strategy to advance 3D biology, the additional footprint will be used to demonstrate the value of integrated technologies that automate workflows for cell line development, organoid development, and high-content screening, while also serving as an enriching space to foster additional R&D initiatives and industry collaborations.
Key Points:
- , a leading provider of high-performance life science solutions, celebrated the completed expansion of its Austrian Research & Development Center .
- "I'd like to thank Molecular Devices and the company's management team for their ongoing engagement investing into the local talents and economy."
- Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development.
- Molecular Devices is committed to the continual development of innovative solutions for life science applications.